An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received Clevudine

A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients

NCT01266005 ·Status: TERMINATED ·Phase: PHASE4

An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B

NCT01264354 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group

NCT00313261 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV

NCT00501124 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)

NCT01264367 ·Status: COMPLETED ·Phase: PHASE4

A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCC

NCT01263002 ·Status: COMPLETED ·Phase: PHASE4

Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV

NCT00313287 ·Status: TERMINATED ·Phase: PHASE3

Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients

NCT00798460 ·Status: TERMINATED ·Phase: PHASE4

A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function

NCT00641082 ·Status: COMPLETED ·Phase: PHASE4

Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV

NCT00313274 ·Status: TERMINATED ·Phase: PHASE3

Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients

NCT00558493 ·Status: COMPLETED ·Phase: PHASE4

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

NCT00044135 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus

NCT00305019 ·Status: TERMINATED ·Phase: PHASE2

A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection

NCT06311734 ·Status: COMPLETED ·Phase: PHASE1

Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria

NCT04264312 ·Status: COMPLETED

Study of Bulevirtide in Participants With Chronic Hepatitis D Infection

NCT05718700 ·Status: ACTIVE_NOT_RECRUITING

Study of LW231 in Participants With Chronic Hepatitis B

NCT07179575 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of LP-128 Capsules in Healthy Subjects

NCT05130567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine

NCT02693652 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine

NCT04289987 ·Status: COMPLETED ·Phase: PHASE2

Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation

NCT02125071 ·Status: COMPLETED

The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients

NCT03546530 ·Status: COMPLETED ·Phase: NA

Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude

NCT02523547 ·Status: UNKNOWN ·Phase: PHASE4

An Study of Efficacy and Safety of Clevudine

NCT01192854 ·Status: COMPLETED ·Phase: PHASE3

Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection

NCT00362635 ·Status: COMPLETED ·Phase: PHASE3